机构

• 上海药物研究所 [49]
• 长春应用化学研究所 [9]
• 化学研究所 [6]
• 过程工程研究所 [3]
• 重庆绿色智能技术研究... [2]
• 合肥物质科学研究院 [2]
• 更多

采集方式

• OAI收割 [82]

内容类型

• 期刊论文 [80]
• 学位论文 [2]

发表日期

• 2025 [1]
• 2024 [2]
• 2023 [3]
• 2022 [4]
• 2021 [8]
• 2020 [6]
• 更多

学科主题

• Chemistry [4]
• Pharmacolo... [2]
• Biochemist... [1]
• Chemistry,... [1]
• Nutrition ... [1]
• 环境科学::环境化学 [1]
• 更多

筛选

浏览/检索结果: 共82条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A prodrug nanodevice co-delivering docetaxel and ROR1 siRNA for enhanced triple negative breast cancer therapy 期刊论文  OAI收割 ACTA BIOMATERIALIA, 2025, 卷号: 193, 页码: 498-513 作者:  Yin, Lixuan;  Fu, Zirang;  Wang, Mengmeng;  Liu, Bo;  Sun, Xujie   |  收藏  |  浏览/下载：15/0  |  提交时间：2025/04/01 Triple-negative breast cancer  Docetaxel  Prodrug nanoparticle  ROR1 siRNA  pH responsive   Advancements and challenges in immunocytokines: A new arsenal against cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 11, 页码: 4649-4664 作者:  Shi, Wenqiang;  Liu, Nan;  Lu, Huili   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/12/25 Bifunctional fusion  Combination therapy  Tumor-conditional  Prodrug   PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 12 作者:  Zhang, Shunan;  Lai, Yi;  Pan, Jiaxing;  Saeed, Madiha;  Li, Shiqin   |  收藏  |  浏览/下载：38/0  |  提交时间：2024/04/09 active tumor targeting  nanosensitizer  PROTAC prodrug  radiation therapy  tumor microenvironment   A prodrug of the capsid assembly modulator improved druggability and lowing HBsAg and HBeAg for the treatment of chronic hepatitis B 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 257, 页码: 8 作者:  Chen, Wuhong;  Gong, Ying;  Long, Guozhang;  Wang, Xinran;  Yang, Yurong   |  收藏  |  浏览/下载：23/0  |  提交时间：2023/10/17 HBV  Capsid assembly modulators  Prodrug  Hepatitis B surface antigen   Stimuli-activatable PROTACs for precise protein degradation and cancer therapy 期刊论文  OAI收割 SCIENCE BULLETIN, 2023, 卷号: 68, 期号: 10, 页码: 1069-1085 作者:  Gao, Jing;  Yang, Lei;  Lei, Shumin   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/10/17 PROTAC  Stimuli-activatable prodrug  Precise protein degradation  Nanomedicine  Combinatory therapy   Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2023, 卷号: 130, 页码: 20 作者:  Chen, Yuting;  Shi, Qiongyu;  Yang, Hong;  Li, Jiayi;  Zhou, Kaixin   |  收藏  |  浏览/下载：33/0  |  提交时间：2023/04/10 Epigenetic  PRMT5 inhibitor  Nucleoside derivatives  Structure-activity Relationship Prodrug   In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 11 作者:  Hou, Bo;  Ye, Jiayi;  Li, Junhao;  Xu, Zhiai;  Yu, Haijun   |  收藏  |  浏览/下载：45/0  |  提交时间：2023/04/10 Immune-excluded tumor  Extracellular matrix  In-situ click reaction  Prodrug nanoparticles  Immune resistance   Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas 期刊论文  OAI收割 PHARMACEUTICS, 2022, 卷号: 14, 期号: 8, 页码: 12 作者:  Chang, Shih-Jen;  Wang, Huiyuan;  Chen, Jialin;  Chen, Qianyi;  Chang, Lei   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/09/30 infantile hemangioma  timolol maleate  butyryl timolol maleate  prodrug  sequelae  hydrolysis   Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment 期刊论文  OAI收割 ACTA BIOMATERIALIA, 2022, 卷号: 147, 页码: 356-365 作者:  Huang, Xiaobei;  Mu, Ning;  Ding, Yuanfu;  Lam, Hou Wang;  Yue, Ludan   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/08/22 Photodynamic-chemotherapeutic therapy  Pt(IV) prodrug  Charge -reversal  Targeted drug delivery  Controlled drug release   Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 6, 页码: 2695-2709 作者:  Ye, Jiayi;  Hou, Bo   |  收藏  |  浏览/下载：30/0  |  提交时间：2024/03/21 Immunotherapy  Prodrug nanoparticles  Immune evasion  Immunogenic cell death  Tumor microenvironment